Lars Jøran Kjerpeseth’s research looks at the use of oral anticoagulants to prevent stroke in patients with atrial fibrillation.


MAIN RESULTS:

  1. Prescription of novel oral anticoagulants increases fast in patients with atrial fibrillation.
  2. Patients with previous stroke are more likely to get novel oral anticoagulants instead of warfarin.
  3. Patients with heart failure and diabetes are more likely to get a warfarin prescription.

THESIS DEFENCE:

Thesis: Oral anticoagulation for stroke prevention in atrial fibrillation: Data from the Norwegian Prescription Database, the Norwegian Patient Registry and the Norwegian Cause of Death Registry
Candidate: Lars Jøran Kjerpeseth
Time: May 28, 2019 at 13:15
Place:St. Olavs Hospital, Medical Technical Research Center: Auditorium MTA
Link to university website (in Norwegian)


SUMMARY:

(1) 2015 was the first year the use of novel oral anticoagulants surpassed the use of warfarin in patients with atrial fibrillation in Norway. The new oral anticoagulants were introduced in Norway in 2011. A total of 129 285 patients with atrial fibrillation received a prescription for anticoagulant treament in Norway from 2011 to 2015, with a gradual increase throughout the period.

(2) In 2015, 86 % av all new users of oral anticoagulants received a prescription for one of the novel drugs. Atrial fibrillation patients with vascular disease, heart failure and diabetes were less likely to receive novel oral anticoagulants instead of warfarin. Women and patients with a previous stroke had increased likelihood of receiving novel oral anticoagulants.


REFERENCES:

(1) Kjerpeseth, L. J., Ellekjaer, H., Selmer, R., Ariansen, I., Furu, K., & Skovlund, E. (2017). Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015European journal of clinical pharmacology73(11), 1417-1425.

(2) Kjerpeseth, L. J., Ellekjaer, H., Selmer, R., Ariansen, I., Furu, K., & Skovlund, E. (2018). Risk factors for stroke and choice of oral anticoagulant in atrial fibrillationEuropean journal of clinical pharmacology74(12), 1653-1662.

Latest News

April 28, 2024

Professor Kristina H. Haugaa receives the 2024 Heart Research Award

The Norwegian Health Association has awarded the prestigious 2024 Heart Research Award (Hjerteforskningsprisen) to professor Kristina…

Read more
September 08, 2023

Annual Symposium 2023: Winners and photos

More than 100 participants attended the 21st Annual Norwegian Symposium on Heart Research, hosted by…

Read more
April 30, 2023

Professor Dan Atar receives the 2023 Heart Research Award

The Norwegian Health Association has awarded the prestigious 2023 Heart Research Award (Hjerteforskningsprisen) to professor Dan…

Read more
October 31, 2022

Pictures from Introductory Course to Cardiovascular Research and Medicine 2022

23 students completed NORHEART’s Introductory Course to Cardiovascular Research and Medicine in Oslo 17–21 October. As usual,…

Read more
Norheart uses cookies for analytical purposes, content and ads customisation, and to further develop our services.
Accept
Learn more
Show again